Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biological markers and schizophrenia.

D Copolov1, J Crook

  • 1The Mental Health Research Institute of Victoria, Parkville, Australia. dlc@mhri.edu.au

The Australian and New Zealand Journal of Psychiatry
|December 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Biochemical Control of a Prospective Cohort of Prostate Cancer Patients Treated With Interstitial Brachytherapy Versus Radical Prostatectomy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Reply to: Who Should Bear the Cost of Convenience? A Cost-effectiveness Analysis Comparing External Beam and Brachytherapy Radiotherapy Techniques for Early Stage Breast Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2017
Same author

Use of magnetic resonance imaging in low-dose-rate and high-dose-rate prostate brachytherapy from diagnosis to treatment assessment: Defining the knowledge gaps, technical challenges, and barriers to implementation.

Brachytherapy·2017
Same author

Transperineal biopsies of MRI-detected aggressive index lesions in low- and intermediate-risk prostate cancer patients: Implications for treatment decision.

Brachytherapy·2016
Same author

Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data.

Clinical oncology (Royal College of Radiologists (Great Britain))·2016
Same author

A dissociation of structure and function in the auditory cortex of patients with schizophrenia.

Acta neuropsychiatrica·2016

Identifying biological markers for schizophrenia could aid early intervention. While several promising markers exist, none are yet suitable for widespread clinical use due to limitations in predictive validity and practicality.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biomarker Research

Background:

  • Schizophrenia poses a significant public health challenge.
  • Early identification of at-risk individuals is crucial for preventative strategies and minimizing morbidity.
  • Biological markers could facilitate early detection and intervention in schizophrenia.

Purpose of the Study:

  • To review selected biological measures that may indicate an elevated risk for schizophrenia.
  • To assess the current status and potential of these markers for early schizophrenia detection.

Main Methods:

  • A selective review of intensively studied putative biological markers for schizophrenia.
  • Key markers examined include enlarged cerebral ventricles, dopamine D2 receptor density, dopamine release, plasma homovanillic acid, and eye tracking dysfunction.

Related Experiment Videos

Main Results:

  • Several biological measures have demonstrated correlations with schizophrenia.
  • These include neuroimaging findings, neurochemical indicators, and functional measures like eye tracking.

Conclusions:

  • Currently, no single biological marker possesses satisfactory predictive validity, non-invasiveness, ease of testing, and low cost for widespread clinical application.
  • Further research and development are needed for promising markers to enable their practical use in identifying individuals at risk for schizophrenia.